New Treatment Approved for Duchenne muscular dystrophy (DMD)

The FDA has just granted approval of deflazacort (brand name Emflaza) for the treatment of Duchenne muscular dystrophy (DMD). This is the third drug approved by the FDA in six months for our families! Thank you all for the countless hours you invest into MDA’s mission and the golf tournament that make these milestones possible!

You can read more about this news here.

Sign Up for FUELSNews

The daily market newsletter produced by Mansfield Energy Corp.

FUELSNews 360° Quarterly Report

Click to Subscribe & Download Q1 2017 Now